Vericel (Vericel) Days Payable : 103.48 (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Vericel Days Payable?

Vericel's average Accounts Payable for the three months ended in Dec. 2023 was $18.7 Mil. Vericel's Cost of Goods Sold for the three months ended in Dec. 2023 was $16.5 Mil. Hence, Vericel's Days Payable for the three months ended in Dec. 2023 was 103.48.

The historical rank and industry rank for Vericel's Days Payable or its related term are showing as below:

VCEL' s Days Payable Range Over the Past 10 Years
Min: 57.38 Med: 79.72 Max: 115.73
Current: 94.11

During the past 13 years, Vericel's highest Days Payable was 115.73. The lowest was 57.38. And the median was 79.72.

VCEL's Days Payable is ranked worse than
60.36% of 714 companies
in the Biotechnology industry
Industry Median: 146.16 vs VCEL: 94.11

Vericel's Days Payable increased from Dec. 2022 (79.10) to Dec. 2023 (103.48). It may suggest that Vericel delayed paying its suppliers.

Vericel Days Payable Historical Data

The historical data trend for Vericel's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vericel Days Payable Chart

Vericel Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

65.35

59.84

57.38

86.76

115.73

Vericel Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Payable	Get a 7-Day Free Trial															79.10	88.29	72.88	89.74	103.48

Competitive Comparison of Vericel's Days Payable

For the Biotechnology subindustry, Vericel's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vericel's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vericel's Days Payable distribution charts can be found below:

* The bar in red indicates where Vericel's Days Payable falls into.

Vericel Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Vericel's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (16.93	+	22.347)	/	2 )	/	61.94	*	365
=	19.6385					/	61.94	*	365
=	115.73

Vericel's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (15.051	+	22.347)	/	2 )	/	16.489	*	365 / 4
=	18.699					/	16.489	*	365 / 4
=	103.48

Vericel Days Payable Related Terms

Thank you for viewing the detailed overview of Vericel's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Vericel (Vericel) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vericel Corp (NAS:VCEL) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

ATQP:Germany

Address

64 Sidney Street, Cambridge, MA, USA, 02139

Website

https://www.vcel.com

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company, specialized in advanced therapies for sports medicine and severe burn care markets. It markets two cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane) and Epicel (cultured epidermal autografts). The company operates in one reportable segment: the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.

Executives

Dominick Colangelo	director, officer: President and CEO	1000 WINTER ST., SUITE 2200, WALTHAM MA 02451
Zerbe Robert L Md	director
Paul K Wotton	director	C/O ANTARES PHARMA, INC., 707 EAGLEVIEW BOULEVARD, SUITE 414, EXTON PA 19341
Sean C. Flynn	officer: SVP, General Counsel	C/O VERICEL CORPORATION, 64 SIDNEY ST., CAMBRIDGE MA 02139
Michael Halpin	officer: Chief Operating Officer	C/O VERICEL CORPORATION, 64 SIDNEY ST., CAMBRIDGE MA 02139
Jonathan Mark Hopper	officer: Chief Medical Officer	64 SIDNEY STREET, CAMBRIDGE MA 02139
Jonathan Siegal	officer: Principal Accounting Officer	C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE MA 02139
Lisa Wright	director	C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE MA 02139
Mara Joseph Anthony Jr	officer: Chief Financial Officer	C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE MA 02139
Steven C Gilman	director	110 HARTWELL AVENUE, LEXINGTON MA 02421
Sandra Pennell	officer: VP and Corporate Controller	C/O VERICEL CORPORATION, 64 SIDNEY STREET, CAMBRIDGE MA 02139
Gerard J Michel	officer: CFO & VP , Corp. Development	420 CHIPETA WAY, SALT LAKE CITY UT 84108
Daniel Orlando	officer: Chief Operating Officer	P.O. BOX 376, ANN ARBOR MI 48105
Alan L Rubino	director	PO BOX 376, LOBBY L., ANN ARBOR MI 48105
Consonance Capital Management Lp	10 percent owner	1370 AVENUE OF THE AMERICAS, SUITE 3301, NEW YORK NY 10019